Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 DAC vs. No DAC: Quick Comparison

Feature CJC-1295 with DAC CJC-1295 No DAC / Modified GRF (1-29) Core identity Long-acting GHRH analog Short-acting GHRH analog DAC present? Yes No Albumin binding Yes — covalent albumin binding No DAC-mediated albumin binding Half-life Approximately 5.8–8.1 da

This comparison does not assign a generated winner or score.

  • Feature
  • CJC-1295 with DAC
  • CJC-1295 No DAC / Modified GRF (1-29)
  • Core identity
  • Long-acting GHRH analog
  • Short-acting GHRH analog
  • DAC present?
  • Yes
  • No
  • Albumin binding
  • Yes — covalent albumin binding
  • No DAC-mediated albumin binding
  • Half-life
  • Approximately 5.8–8.1 days in human studies²
  • Much shorter; closer to modified GHRH fragment behavior
  • Signaling pattern
  • Sustained GH/IGF-1 stimulation
  • Shorter, more pulsatile GHRH-like stimulation
  • Main research focus
  • Long-duration GH-axis activation
  • Short-duration GH pulse modeling
  • Key distinction
  • Extended duration through DAC
  • Faster clearance without DAC
More references

Related material